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A b s t r a c t
Background and aim: The aim of this study was to determine the long-term survival of DDD pacing and identify the main 
reasons for its loss.
Methods: The study group consisted of 496 patients in whom a DDD pacing system was implanted between October 1984 and 
March 2002 and who were followed up until July 2010. The follow-up period was 152.1 ± 35.5 months. The patients’ mean 
age at the time of implantation was 59.5 ± 12.5 years, and 53.5% were male; 58% had sick sinus syndrome (SSS), 26% had 
atrioventricular block (AVB), 15% had both of these indications simultaneously, and 1% had other indications. The incidence 
of lead malfunction, progression to chronic atrial fibrillation (AF), and the rate of infective complications was analysed.
Results: During the follow-up, 369 patients remained in DDD mode stimulation. DDD mode survival rate at one, five, ten 
and 15 years was, respectively, 96%, 86%, 77% and 72%. The most common reason for reprogramming out of DDD mode 
was the development of permanent AF in 65 (13.1%) patients. The occurrence of chronic AF was associated with a prior 
history of paroxysmal AF (p = 0.0001), SSS (p = 0.0215), and older age at time of implantation (p = 0.0068) compared to 
patients who remained in sinus rhythm. Lead malfunction caused loss of DDD mode pacing in 56 (11.3%) patients. Atrial leads 
were damaged in 37 patients, ventricular in 12 patients, and both leads in seven patients. The subclavian vein puncture was 
correlated with the mechanical damage of the atrial lead (p = 0.02935) compared to cephalic vein access. At the moment 
of complication, the patients with a dysfunctional lead were significantly younger than those who progressed to chronic AF 
(p = 0.0019). Infective complications which caused temporary loss of DDD pacing were observed in six patients: five had 
pocket infection and one had lead-dependent infective endocarditis.
Conclusions: 1. Effective DDD pacing from the originally implanted system was noted in a high percentage (72%) of patients 
in long-term observation (15 years). 2. Progression to permanent AF is the most common reason for loss of DDD pacing; 
a history of paroxysmal AF and old age are the risk factors. 3. Subclavian vein puncture is associated with a higher rate of 
atrial lead damage.
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INTRODUCTION
Permanent cardiac pacing has been a recognised treatment 
of symptomatic bradycardia since the mid 20th century [1]. 
Initially, pacemakers were able to stimulate a single cardiac 
cavity, usually the right ventricle, as V00 cardiac pacing and 
then VVI. Ventricular stimulation with ventricular pacing 
synchronous with the P wave, described in 1963, preserved 
atrioventricular synchrony [2]. Atrioventricular stimulation 
(DVI, DDD) called physiological appeared at the beginning 
of the 1980s [3], and the main indications for its implanta-
tion have become atrioventricular block (AVB) and sick sinus 
syndrome (SSS). After implantation of atrioventricular pace-
makers, an improvement in quality of life [4, 5] and survival 
of patients has been observed [6]. This improvement was 
first of all associated with the reduction of pacemaker syn-
drome [5]. In addition, it has been proved that DDD mode 
pacing reduces the incidence of permanent atrial fibrillation 
(permAF) by two-thirds, and the risk of death by one-third, 
compared to ventricular pacing (VVI) [7]. The DANPACE study 
[8] revealed the advantage of DDD stimulation over atrial 
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stimulation (AAI) in the prevention of AF. Dual chamber pacing 
is more complicated than single chamber (AAI and VVI) due 
to the implantation of two endocardial leads. This prolongs 
implantation time and evaluation of the device, and requires 
a more experienced operator [9]. At follow-up of patients 
treated with DDD pacing, there are clinical situations that 
force programme pacing to be downgraded, mainly to VVI. 
Atrial arrhythmias (permAF and atrial flutter) and dysfunction 
of the endocardial leads are the most common reason for this 
reprogramming. Durability of DDD pacing system has been 
assessed in a number of reports. A prospective study compared 
a follow-up of DDD and VDD stimulation in patients with 
AVB [10]. In this study, 254 patients received dual-chamber 
pacemakers, the follow-up lasted on average for 25 months, 
the DDD mode survival was 89.3% at the end of the study, 
and 8.7% of patients developed permAF. Most studies on 
the long-term efficacy of DDD pacing are retrospective and 
come from the early period of implantation history — the 
1980s and early 90s. In the cited articles, a follow-up of nearly 
3,000 dual-chamber pacemaker patients is described [11–16]. 
In the follow-up periods ranging from 30 to 44 months, it 
was necessary to abandon DDD stimulation in 4.3–18% of 
cases. The main reason for the loss of DDD pacing mode was 
the occurrence of permAF and atrial flutter. Gross et al. [14] 
and Ibrahim et al. [15] showed that DDD pacing mode survival 
after five years was, respectively, 78% and 83.5%. In longer 
follow-up (an average of 81 months), DDD pacing mode sur-
vival after five years was 90%, and after 15 years — 58% [16]. 
In a study investigating a Polish population of 295 patients with 
DDD pacemakers implanted between 1994 and 1997, Ma-
jewski et al. [17] reported that after an average of 63 months 
of follow-up, pacing mode was changed to VVI in 18% of 
patients; in 13% of patients there occurred permAF, and in 
5% atrial lead damage. Several authors have shown that SSS 
among the indications [6, 14, 17] and history of paroxysmal 
AF (paroxAF) before implantation [14, 17] are statistically more 
frequent in patients who developed permAF. Endocardial lead 
damage in the DDD pacing system in a Polish population of 
977 patients was analysed by Małecka et al. [18]. She showed 
that in a long-term follow-up (mean 59 months), atrial and 
ventricular lead failure occurred respectively in 8.3% and 4% 
of cases. In that study, the authors attempted to demonstrate 
the influence of venous access and the construction of leads 
on the incidence of lead failure [18]. 
However, there is a lack of sufficiently well-established 
opinions on the durability of DDD pacing systems, including 
those implanted since the late 20th century. For that reason, 
we decided to present our experience. 
The aim of this study was the analysis of the occurrence of 
temporary or permanent loss of primary DDD pacing system 
in long-term follow-up and the identification of causes of this 
loss: development of permAF, endocardial lead malfunction 
and infections. 
METHODS
We reviewed the records of all patients with implanted dual 
chamber pacemakers (1,086) between October 1984 and 
March 2002. The necessary condition to enroll the patients 
to the study was the regularity of their follow-up examinations 
of at least once a year until July 2010. We decided to assess 
only the population who were in follow-up at the time of data 
collection in order to be able to recall the patient to examine 
them. These criteria were fulfilled by 496 patients. 590 pa-
tients were lost to follow-up before 2010; in a few cases they 
changed their pacemaker centre, but the majority of them 
died. We chose the period 1984–2002 because it was the 
initial stage of DDD pacemaker implantation in the centre. 
Before 2002, only leads with passive fixation were used. 
Because of centralised purchasing from Biotronik, leads from 
this provider were utilised in the majority of patients (89%). 
The metal wire in atrial leads TIJ 53 UP and DJP 53 UP from 
Biotronik consisted of three microfilaments, whereas the atrial 
and ventricular leads consisted of four.
We gathered information for the purpose of this study 
from electronic database Impuls-BIS by ITAM, and IMPULS. 
Supplementary information was derived from the records of 
outpatient clinics and the operative reports. The information 
reviewed included: 1. Patient demographics: gender, age at 
the time of: a) implantation, b) DDD pacing loss; 2. Indica-
tion for implantation: a) SSS, b) AVB: 2nd and 3rd degree, 
c) the occurrence of both of these indications simultaneously 
(SSS + AVB), d) other; 3. Presence or absence of a history 
of paroxAF before implantation, 4. Lead model (unipolar, 
bipolar) and the number of microfilaments comprising the 
lead, 5. Venous access (cephalic venesection, subclavian 
vein puncture), 6. Duration of follow-up, 7. Reason for loss 
of the primary DDD pacing mode including development of 
permAF, lead damage and infection related to pacing system.
We evaluated the incidence and causes of loss of the 
DDD pacing. The diagnosis of lead malfunction was based 
on the presence of increased capture threshold, failure to 
sense, and/or alterations in lead impedance. Mechanical lead 
damage was confirmed if possible by chest X-ray. PermAF was 
defined as AF found on two consecutive visits to an outpatient 
clinic. AF diagnosis was based on the electrocardiogram (ECG) 
records (leads I and II) stored in the IMPULS database, and 
printouts of intracardiac electrogram in atrial channel from 
the pacemaker programmer. About a dozen of the patients 
were called for additional ECG and chest X-ray examina-
tions. Infection caused both by lead-dependent infective 
endocarditis and pocket infection led to loss of DDD pacing 
due to extraction of leads and the devices. 
Statistical analysis
The data was evaluated using Statistica 10. Normality was 
tested using Shapiro-Wilk test. Mann-Whitney U test was used 
for non-normal distributions. Kruskal-Wallis test was used to 
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of pacemakers were still in the primary DDD pacing; at six 
months 97%, at one year 96%, at five years 86%, at ten years 
77% and at 15 years 72%. The curves showing the loss of 
DDD due to the development of permAF and lead failure 
did not differ significantly (Fig. 1). Indications for pacemaker 
implantation are presented in Table 1.  
Analysis of group of patients  
who developed permanent AF
The most common reason for downgrading from DDD to VVI 
mode was the permAF development noted in 65 (13.1%) pa-
tients, after an average of 58.9 ± 43.4 months of stimulation. 
PermAF occurred in 46 patients with SSS after an average of 
58.3 ± 44.1 months, in nine patients with AVB after an aver-
age of 55.1 ± 43.7 months, and in ten patients with SSS and 
AVB after an average of 63.2 ± 44.2 months of stimulation. 
Indications for pacemaker implantation had no influence on 
time to progression to permAF (Kruskal-Wallis test = 0.1827, 
p = 0.9127). All patients remained in VVI mode pacing until 
the end of follow-up. The group of patients who developed 
permAF was compared to the rest of the patients (Table 2). 
There was a substantially greater prevalence of history of 
paroxAF (p = 0.0001, c2 = 23.2654), SSS (p = 0.0215, 
c2 = 5.2858) and older age (p = 0.0068, U = 11093.5) at 
the time of implantation in the group that developed permAF 
(Table 2). 
Analysis of group of patients with lead failure
Endocardial lead malfunction caused temporary or perma-
nent absence of DDD pacing in 56 (11.3%) patients (Fig. 2). 
In 37 patients (66% of patients with lead failure) atrial leads 
failed. In the whole study population, atrial leads were 
implanted through subclavian vein puncture (79%) or vene-
section of cephalic vein (21%). The implantation technique 
significantly affected the risk of atrial lead failure. Subclavian 
vein puncture led to lead failure more often than a cephalic 
vein approach (p = 0.02935, c2 = 4.747233). Ventricular lead 
damage was observed in 12 patients (21% of patients with 
lead failure). In the whole study population, ventricular leads 
were implanted through subclavian vein puncture (34%) and 
venesection of cephalic vein (66%). The influence of implanta-
tion technique on the frequency of ventricular lead failure was 
compare more than two independent groups of non-normal 
distribution. Data is presented as mean with standard de-
viations, additionally in tables as median and interquartile 
range (IQR). Groups were compared with the c2 test with 
one degree of freedom for discrete variables. Event-free rates 
were calculated with Kaplan-Meier analysis. The first event 
was counted as an end point in each case. Clinical variables 
were submitted to multivariate analysis. Predictors of loss of 
DDD and predictors of lead damage were assessed using 
a Cox’s proportional-hazards model. A p value < 0.05 was 
considered significant.  
RESULTS
We analysed the population of 496 patients, whose mean 
age at the time of implantation was 59.5 ± 12.5 years; 
265 (53.5%) patients were male. The 590 patients who were 
lost to follow-up were significantly older at the time of im-
plantation: 66.0 ± 30.3 vs. 59.5 ± 12.5 years; p < 0.0001. 
The mean follow-up duration in the analysed popu-
lation was 152.1 ± 35.5 months, ranging from 101 to 
302 months. During follow-up, 127 (25.6%) patients lost 
primary DDD stimulation. After a month of follow-up, 99% 
Table 1. Indications for DDD pacing
Indications for the implantation SSS SSS and AVB AVB Others All patients
Number of patients 287 (58%) 74 (15%) 127 (26%) 8 (1%) 496 (100%)
Age at the time of implantation  
(median, IQR) [years]
60.7 ± 11.5
(62.9; 16.3)
60.9 ± 12.1
(63.9; 18.8)
56.6 ± 14.2
(60.2; 21.1)
52.5 ± 13.0
(49.4; 17.4)
59.5 ± 12.5
(62.5; 18.3)
Number of patients with PAF 51 10 10 0 71
SSS — sick sinus syndrome; AVB — atrioventricular block; IQR — interquartile range; PAF — paroxysmal atrial fibrillation
Figure 1. Cumulative maintenance of DDD pacing mode by 
Kaplan-Meier analysis; PermAF — permanent atrial fibrillation
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of borderline statistical significance. Subclavian vein puncture 
led to lead failure more often than a cephalic vein approach 
(p = 0.05034, c2 = 3.830233). Malfunction of both leads was 
demonstrated in seven patients (13% of patients with lead 
failure). In these patients, it could not be determined which 
had happened earlier — atrial or ventricular lead damage. 
In addition, we conducted an analysis of the impact of 
lead metal wire structure on lead damage. Three-microfila-
ment leads (4.4% of Biotronik leads) were implanted in 39 pa-
tients: 11 by venesection of cephalic vein, and 28 through 
subclavian vein puncture. It was found that the subclavian vein 
puncture increased the incidence of three-microfilament lead 
failure, compared to four-microfilament leads (p = 0.00002, 
c2 = 18.28216). The cephalic approach did not influence the 
rate of failure (three- vs. four-microfilaments; p = 0.62634, 
c2 = 0.2370526). In multivariate analysis, only the implanta-
tion of a three-microfilament lead was associated with an 
increased risk of lead damage (hazard ratio [HR] = 2.20; 
confidence interval [CI] 1.10–4.39, p = 0.0259) (Table 3).
Comparison of patients with progression  
to permanent AF to patients with lead failure
We observed that the patient’s age at the moment of primary 
DDD pacing loss had a statistically significant association with 
the cause of this loss — younger patients (61.5 ± 15.1 years) 
more frequently had lead malfunction, while in older patients 
(70.0 ± 9.7 years), the loss of DDD pacing was mainly due 
to the development of permAF (U = 1243.0, p = 0.0019). 
ParoxAF before pacemaker implantation (p = 0.0026; 
c2 = 9.0689) and SSS indication (p = 0.0194; c2 = 5.4651) 
occurred significantly more often in patients who progressed 
to permAF. AVB indication was present significantly more often 
in the group with lead damage (p = 0.0159, c2 =5.8139). It 
was also observed that the gender and duration of stimula-
tion had no statistically significant correlation with the cause 
of DDD pacing loss (Table 4).
Infections related to pacing system were identified in 
six (1.2%) patients: five had a pocket infection and one had 
a lead-dependent infective endocarditis. In all of these pa-
Table 2. Comparison of the group of patients who progressed to permanent atrial fibrillation — group 1 — to  the rest of the 
patients — group 2
Group 1: patients  
with permanent AF (n = 65)
Group 2: patients without  
permanent AF (n = 431)
Test result P
Sick sinus syndrome 55 (85%) 306 (71%) 5.2858 (c2) 0.0215
Paroxysmal AF 22 (34%) 49 (11%) 23.2654  (c2) 0.0001
Age at time of implantation  
(median, IQR) [years]
63.7 ± 9.1
(56.6; 11.3)
58.9 ± 12.8
(61.7; 19.4)
11,093.5 (U) 0.0068
Men 34 (52%) 232 (54%) 0.0525 (c2) 0.8187
AF — atrial fibrillation; IQR — interquartile range; U — Mann-Whitney U test, c2 —  Chi square test
Figure 2. Pacing mode changes of patients with lead failure; FU — follow-up; PM — pacemaker; pts — patients
www.kardiologiapolska.pl
Long-term follow-up of DDD pacing mode
523
tients, the whole system was removed. In four patients, the 
new DDD pacing system was implanted at the contralateral 
side of the chest, in one a VVI system was implanted, and in 
one patient there was no further indication to pacing therapy. 
Surgical site infection occurred in two cases after first implan-
tation (an incidence rate of 0.5/1000 pacemaker-year) and 
in four cases after replacement (1.4/1000 pacemaker-year). 
In multivariate analysis, paroxAF remained the only 
significant factor for DDD loss (HR = 2.09; CI 1.37–3.18; 
p = 0.0006) (Table 5). In the group of 127 patients who lost the 
primary DDD pacing system, 65 patients lost it due to permAF, 
56 patients lost it due to lead failure, and six due to infective 
complications. In 29 cases, DDD pacing was reconstructed.
DISCUSSION
This study describes the clinical outcome of a large group 
of patients who underwent DDD pacemaker implanta-
tion between 1984 and 2002 and remained in long-term 
follow-up until 2010. The rest of the older patients who 
received DDD pacemakers in this period at some point were 
lost to follow-up. This was caused by the consequences of 
ageing which are senility and death, and in a minority of 
cases by a change of place of residence, and thus change 
of pacemaker centre. The mean follow-up duration in this 
study was 152.1 ± 35.5 months, which is the longest time of 
observation of DDD pacemakers among the studies cited in 
the references. We observed the loss of primary DDD pacing 
system in 25.6% of patients. Though this value is higher than 
in other studies, in equally long durations of follow-up our 
percentage of the loss of DDD is the same or even lower. 
A five-year cumulative rate of DDD pacing survival was 87%, 
whereas in other studies it was 78–90% [14–16].
The most common reason for the loss of DDD pacing was 
permAF development, occurring in 13.1% of the patients. Pre-
Table 3. Multivariate analysis of risk factors for lead damage in the group of Biotronik leads (89% of leads in assessed population)
Parameter Hazard ratio 95% confidence interval P
Three-microfilament lead 2.20 1.10–4.39 0.0259
Subclavian access 1.15 0.76–1.75 0.5145
Table 4. Comparison of patients who progressed to permanent atrial fibrillation (AF) to patients with lead failure
Reason for loss of DDD stimulation Lead failure Permanent AF Test result P
Number of the patients 56 65 – –
Men 51.8% 50.8% 0.0124 (c2) 0.9112
Age at the time of loss of stimulation  
(median, IQR) [years]
61.5 ± 15.1
(63.9; 23.3)
70.0 ± 9.7
(72.2; 9.4)
1,243.0 (U) 0.0019
Duration of stimulation 
(median, IQR) [months]
62.0 ± 43.6
(61.3; 66.7)
57.6 ± 43.7
(55.4; 65.9)
1,725.5 (U) 0.5307
Indications [number of patients]:
Sick sinus syndrome (SSS) 28 46 5.4651 (c2) 0.0194
Atrioventricular block (AVB) 18 9 5.8139 (c2) 0.0159
SSS + AVB 10 10 0.1333 (c2) 0.7150
History of paroxysmal AF [number of patients] 6 22 9.0689 (c2) 0.0026
IQR — interquartile range; U — Mann-Whitney U test, c2 — Chi square test
Table 5. Multivariate analysis of risk factors for loss of DDD stimulation
Parameter Hazard ratio 95% confidence interval P
Age at the time of implantation 1.00 0.99–1.02 0.9806
Female 1.00 0.70–1.42 0.9888
Sick sinus syndrome at implantation 1.38 0.81–2.32 0.2339
Atrioventricular block at implantation 1.26 0.80–1.97 0.3227
Paroxysmal atrial fibrillation prior to implantation 2.09 1.37–3.18 0.0006
Subclavian access of atrial lead 1.05 0.67–1.64 0.8276
Subclavian access of ventricular lead 0.93 0.63–1.37 0.7132
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vious reports have also found that permAF is the most com-
mon reason for mode change. It has ranged from 9% to 13% 
of study populations [13–15, 17]. In prospective studies, in 
which the patients were not lost to follow-up, the incidence 
of AF was slightly higher (11–17%) [4, 8, 10]. Patients who 
developed permAF were older and had more frequently a his-
tory of paroxAF compared to those who remained in sinus 
rhythm. This is consistent with the data from earlier reports 
[14, 17]. Several studies have shown a statistically significant 
association between SSS and the development of AF [6, 14, 
17, 19]. In our study, we obtained similar results. It must be 
noted that the majority of patients with SSS (85%) and a his-
tory of preoperative AF (69%) remained in sinus rhythm until 
the end of follow-up. This means that DDD pacing enables 
pharmacotherapy of arrhythmias which has proved to be ef-
ficient in long-term follow-up. 
Lead failure is one of the most important complications 
during long-term follow-up after DDD pacemaker implanta-
tion. Within our population, lead failure was observed in 
11.3% of the patients. The incidence of lead malfunction 
has been variously reported in the literature as 10.7% after 
26 months [10], 15.5% after 30 months [13], 4.3% after 
40.4 months [12], 16.5% after 60 months [15], 5.1% after 
67.6 months [17], 5% after 81 months [16] and 22.8% after 
91 months [20]. In our study, lead damage occurred more 
frequently to atrial leads (66% of malfunction cases) after 
a mean follow-up of 51 months. Most authors have reported 
similarly [12, 13, 15, 17], although two studies have shown 
that malfunction of ventricular leads was observed more fre-
quently than of atrial leads [20, 21]. Within our population, 
younger patients more often had verified lead failure, which is 
consistent with the results of Helguera et al. [21]. In our study, 
performing the subclavian puncture was associated with more 
structural damage to endocardial leads. Similar results have 
been demonstrated by numerous authors [22–26]. It must be 
mentioned that the influence of type of venous access on lead 
mechanical damage is evident in leads with a weaker structure 
(conductor consisting of three microfilaments), which might 
be attributable to crush syndrome [18]. We emphasise the 
small number of infective complications, much lower than 
in a prospective Danish study [27]. The probable reason for 
this phenomenon is a small team of experienced operators 
who observe strict standards of asepsis.  
Limitations of the study
Our study is limited by its retrospective nature. Due to se-
lection criteria, we assessed only the population who were 
alive at the time of data collection. This might have had 
a considerable impact on the results. Not all risk factors for 
the development of AF were routinely recorded. The effects 
of drug therapy and other patient factors on DDD function 
could not be determined from the database. Despite these 
limitations, the large number of patients and the long duration 
of follow-up all validate our data and make it applicable to 
the general dual chamber pacemaker population.
CONCLUSIONS
1. After long follow-up (15 years), DDD pacing was main-
tained in a high rate of patients (72%) with originally 
implanted DDD systems.
2. The major reason for abandoning DDD mode was the 
development of permAF. 
3. History of paroxAF increases the risk of DDD mode loss.
4. Atrial leads implanted through subclavian vein puncture 
failed significantly more often than leads implanted by 
venesection of cephalic vein. 
5. The implantation of three-microfilament leads is a risk 
factor for lead damage.
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Trwałość stymulacji DDD w obserwacji odległej 
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S t r e s z c z e n i e
Wstęp: Stymulacja DDD jest uznanym sposobem leczenia bloku przedsionkowo-komorowego (AVB) i zespołu chorego węzła 
zatokowego (SSS). W trakcie obserwacji chorych leczonych stymulacją DDD pojawiają się sytuacje kliniczne, które zmuszają 
do przeprogramowania rozrusznika do innego trybu, głównie VVI. 
Cel: Celem pracy były ocena trwałości stymulacji DDD w długoletniej obserwacji i analiza przyczyn jej utraty.
Metody: Do badania zakwalifikowano dokumentację 496 pacjentów z układami DDD implantowanymi w latach 1984–2002, 
pozostających do 2010 r. w kontroli poradni przyklinicznej. Średni czas obserwacji wyniósł 152,1 ± 35,5 miesiąca (8–25 lat). 
We wszczepionych układach stymulujących korzystano w 89% z elektrod firmy Biotronik. Wskazania do stymulacji podzie-
lono na: SSS (58% pacjentów), AVB (26%), występowanie obu tych wskazań jednocześnie (15%) oraz inne wskazania (1%). 
Średni wiek pacjentów w czasie implantacji wynosił 59,5 ± 12,5 roku; było 265 (53,5%) mężczyzn. Oceniano częstość 
występowania uszkodzeń elektrod endokawitarnych, częstość progresji do utrwalonego migotania przedsionków (AF), a także 
powikłań infekcyjnych.
Wyniki: Na koniec czasu obserwacji 369 osób pozostało w stymulacji DDD, odpowiednio po 1, 5, 10 i 15 latach — 96%, 86%, 
77% i 72%. Najczęstszą przyczyną utraty była progresja do utrwalonego AF — u 65 (13,1%) osób, skutkująca zmianą stymulacji 
do trybu VVI u wszystkich pacjentów z utrwalonym AF. W grupie, w której pojawiło się utrwalone AF, w porównaniu z grupą 
z rytmem zatokowym, istotnie statystycznie częściej w wywiadzie zanotowano napadowe AF (p = 0,0001), SSS (p = 0,0215) 
i starszy wiek w momencie implantacji (p = 0,0068). Uszkodzenia elektrod endokawitarnych spowodowały utratę stymulacji 
dwujamowej u 56 (11,3%) pacjentów. Elektrody przedsionkowe uległy uszkodzeniu u 37 osób. Elektrody przedsionkowe 
były implantowane poprzez punkcję żyły podobojczykowej w 79% oraz poprzez wenesekcję żyły odpromieniowej w 21% 
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przypadków. Implantacja metodą punkcji żyły podobojczykowej zwiększała częstość uszkodzeń elektrod przedsionkowych 
w porównaniu z wenesekcją żyły odpromieniowej (p = 0,02935). Elektrody komorowe uległy uszkodzeniu u 12 pacjentów; 
były one implantowane poprzez punkcję żyły podobojczykowej w 34% oraz poprzez wenesekcję żyły odpromieniowej 
w 66% przypadkach. Wykazano, że implantacja metodą punkcji żyły podobojczykowej może zwiększać częstość uszkodzeń 
elektrod komorowych w porównaniu z wenesekcją żyły odpromieniowej (p = 0,05034). Obie elektrody uległy uszkodzeniu 
u 7 osób. Producent elektrod Biotronik udostępnił dane na temat ich budowy. Część elektrod przedsionkowych, tj. TIJ 53 UP 
i DJP 53 UP, była zbudowana z 3 mikrofilamentów, natomiast pozostałe elektrody przedsionkowe i elektrody komorowe 
z 4 mikrofilamentów. Częstość złamań metalowych przewodów elektrod zbudowanych z 3 mikrofilamentów implantowa-
nych metodą punkcji żyły podobojczykowej była większa niż elektrod zbudowanych z 4 mikrofilamentów (p = 0,00002). 
Wśród elektrod implantowanych metodą wenesekcji żyły odpromieniowej nie zaobserwowano podobnej zależności. Wiek 
pacjentów w momencie utraty stymulacji typu DDD różnił się istotnie statystycznie u chorych z uszkodzeniami i progresją 
do utrwalonego AF. Uszkodzenia elektrod endokawitarnych częściej występowały u młodszych pacjentów, natomiast fakt 
rozwinięcia się utrwalonego AF zanotowano u starszych pacjentów (p = 0,0019). Płeć i czas trwania stymulacji nie miały 
istotnego statystycznie związku z przyczyną utraty stymulacji DDD. Powikłania infekcyjne pod postacią infekcji loży stymulatora 
zaobserwowano u 5 osób, a odelektrodowego zapalenia wsierdzia — u 1 chorego.
Wnioski: Wysoki odsetek pacjentów pozostał w trybie stymulacji DDD; 86% po 5 latach, 77% po 10 latach i 72% po 15 la-
tach obserwacji. Najczęstszą przyczyną utraty stymulacji DDD była progresja do utrwalonego AF. Historia napadowego AF 
przed implantacją, SSS i starszy wiek w momencie implantacji okazały się czynnikami ryzyka progresji do utrwalonego AF. 
Średni wiek chorych z utrwalonym AF był istotnie wyższy od wieku pacjentów, u których stwierdzono uszkodzenie elektrody 
endokawitarnej. Implantacja elektrody metodą nakłucia żyły podobojczykowej korelowała z większym ryzykiem uszkodzenia 
elektrody. W przypadku elektrod implantowanych poprzez nakłucie żyły podobojczykowej konstrukcja metalowego przewodu 
elektrody wpływała na ich trwałość; 4-mikrofilamentowe elektrody okazały się trwalsze od 3-mikrofilamentowych.
Słowa kluczowe: zespół chorego węzła zatokowego, blok przedsionkowo-komorowy, rozrusznik serca typu DDD, migotanie 
przedsionków, uszkodzenia elektrod wewnątrzsercowych
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